- Home
- DMLP vs IART Comparison
DMLP vs IART Comparison
Compare DMLP & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMLP
- IART
- Stock Information
- Founded
- DMLP 2003
- IART 1989
- Country
- DMLP United States
- IART United States
- Employees
- DMLP N/A
- IART N/A
- Industry
- DMLP Oil & Gas Production
- IART Medical/Dental Instruments
- Sector
- DMLP Energy
- IART Health Care
- Exchange
- DMLP Nasdaq
- IART Nasdaq
- Market Cap
- DMLP 1.1B
- IART 1.2B
- IPO Year
- DMLP N/A
- IART 1995
- Fundamental
- Price
- DMLP $22.88
- IART $12.42
- Analyst Decision
- DMLP
- IART Hold
- Analyst Count
- DMLP 0
- IART 7
- Target Price
- DMLP N/A
- IART $15.00
- AVG Volume (30 Days)
- DMLP 145.5K
- IART 1.3M
- Earning Date
- DMLP 11-06-2025
- IART 10-30-2025
- Dividend Yield
- DMLP 14.06%
- IART N/A
- EPS Growth
- DMLP N/A
- IART N/A
- EPS
- DMLP 1.13
- IART N/A
- Revenue
- DMLP $143,803,000.00
- IART $1,642,966,000.00
- Revenue This Year
- DMLP N/A
- IART $3.51
- Revenue Next Year
- DMLP N/A
- IART $2.88
- P/E Ratio
- DMLP $20.16
- IART N/A
- Revenue Growth
- DMLP N/A
- IART 4.99
- 52 Week Low
- DMLP $22.56
- IART $10.87
- 52 Week High
- DMLP $34.88
- IART $27.13
- Technical
- Relative Strength Index (RSI)
- DMLP 34.80
- IART 41.44
- Support Level
- DMLP $22.55
- IART $10.87
- Resistance Level
- DMLP $23.87
- IART $12.29
- Average True Range (ATR)
- DMLP 0.60
- IART 0.87
- MACD
- DMLP -0.18
- IART -0.22
- Stochastic Oscillator
- DMLP 13.19
- IART 26.76
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.